Infectious diseases like Mpox aren't just health crises – they're economic time bombs. The recent Mpox outbreak, spreading beyond its traditional strongholds in West and Central Africa to countries like Burundi, Kenya, Rwanda, and Uganda, has exposed the fragility of global supply chains and business operations. But here's where it gets controversial: are businesses doing enough to prepare for the next outbreak?
While the World Health Organization (WHO) and the African Union have mobilized millions to combat the spread, the economic fallout is undeniable. The Democratic Republic of Congo, a long-time battleground against Mpox, faces potential disruptions in supply chains, manufacturing, tourism, and foreign investment. This highlights a stark reality: infectious diseases are not just public health emergencies; they're significant threats to economic stability.
Dr. Isaac Akanko, Medical Director for West & Central Africa at International SOS, emphasizes that businesses need to move beyond mere health compliance. "It's not just about checking boxes," he says. "Companies need to integrate outbreak readiness into their core risk management systems."
In a revealing interview with Nigeria Health Watch, Dr. Akanko dissects the impact of outbreaks like Mpox on businesses. He highlights the often-overlooked ripple effects: disrupted workforces, halted production, delayed shipments, and a cascading effect on global trade. And this is the part most people miss: it's not just about the movement of goods; it's about the movement of people, services, and the very lifeblood of commerce.
So, how can businesses build resilience against Mpox and future outbreaks? Dr. Akanko advocates for tailored, outbreak-specific response plans. Generic templates won't cut it. Companies need to understand the unique characteristics of each disease, its transmission patterns, and the local healthcare landscape.
Effective communication is crucial. "Creating awareness and ensuring access to accurate information is paramount," Dr. Akanko stresses. Businesses have a duty of care to their employees, which includes facilitating access to medical support, health screenings, and vaccines.
But the responsibility doesn't end there. Dr. Akanko urges private sector collaboration with government health authorities. Strengthening local healthcare infrastructure, providing resources like diagnostic facilities and PPE, and supporting isolation centers are vital for containing outbreaks and minimizing economic damage.
The question remains: are businesses prepared to invest in this level of preparedness? While the cost of implementing comprehensive outbreak response plans may seem high, the potential cost of inaction is far greater. The Mpox outbreak serves as a stark reminder that in a globalized world, infectious diseases are everyone's problem. Businesses that fail to adapt risk not only their own survival but also contribute to the vulnerability of the entire global economy.
What do you think? Are businesses doing enough to prepare for the next pandemic? Share your thoughts in the comments below.
